DROSHA and colorectal carcinoma: While the expression of DROSHA was not associated with clinical-pathological features of patients, over-expression of XPO5 is correlated with advanced clinical stage, presence of distant metastases and worse disease-free survival (DFS) and OS, suggesting that this protein has a functional role in CRC progression [31].